Agencourt, Invitrogen, Illumina, Via Pharmaceuticals deal

The parties will participate in a research project to develop a 5-lipoxygenase genotyping panel and an ADMET panel for use in an ongoing Phase II trial of VIAP's VIA-2291 in patients at risk for rec...